Abatacept in Treatment Resistant Nephrotic Syndrome
BWH is now enrolling patients with Nephrotic Syndrome in this clinical trial. Call the Kidney-NExT Clinic at 617-732-6383 to enroll.
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children Over the Age of 6 With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD). Read more about the study.
Center for Kidney Disease and Novel Experimental Therapeutics (Kidney-NExT)